Article
Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.
Toxicology and applied pharmacology - 15 Apr 2009
Jansen Karen L, Cole Toby B, Park Sarah S, Furlong Clement E, Costa Lucio G
Abstract excerpt
A transgenic mouse model of the human hPON1(Q192R) polymorphism was used to address the role of paraoxonase (PON1) in modulating toxicity associated with exposure to mixtures of organophosphorus (OP) compounds. Chlorpyrifos oxon (CPO), diazoxon (DZO), and paraoxon (PO) are potent inhibitors of carboxylesterases (CaE). We hypothesized that a prior exposure to these OPs would increase sensitivity to malaoxon (MO),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
